Knockdown of GLP-1 Receptors in Vagal Afferents Affects Normal Food Intake and Glycemia
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
Nutrient stimulation of enteroendocrine L cells induces the release of the incretin and satiating peptide glucagon-like peptide 1 (GLP-1). The vagus nerve innervates visceral organs and may contribute to the mediation of gut-derived GLP-1’s effects on food intake, energy homeostasis, and glycemic control. To test the hypothesis that vagal afferent neuron (VAN) GLP-1 receptors (GLP-1Rs) are necessary for these effects of endogenous GLP-1, we established a novel bilateral nodose ganglia injection technique to deliver a lentiviral vector and to knock down VAN GLP-1Rs in male Sprague Dawley rats. We found that a full expression of VAN GLP-1Rs is not necessary for the maintenance of long-term energy balance in normal eating conditions. VAN GLP-1R knockdown (kd) did, however, increase meal size and accelerated gastric emptying. Moreover, postmeal glycemia was elevated and insulin release was blunted in GLP-1R kd rats, suggesting that VAN GLP-1Rs are physiological contributors to the neuroincretin effect after a meal. Collectively, our results highlight a crucial role for the VANs in mediating the effects of endogenous GLP-1 on food intake and glycemia and may promote the further development of GLP-1–based therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GLP-1RAs can exert their local effects by activating vagal dendritic terminals that innervate the gut.418–420”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [418]
In the citing paper
“Peripheral GLP-1/GLP-1RAs may also interact with the CNS indirectly by GLP-1R expressed on vagal afferent fibers, signaling via nodose ganglia (57) to the nucleus tractus solitarii within the brainstem.”
From The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medications (2026) · cites this paper as [57]
In the citing paper
“Importantly, knockdown of GLP-1R in VANs increased meal size (39), and abolished the satiating effects of secretagogue-induced GLP-1 release (34).”
From GLP-1 and the Neurobiology of Eating Control: Recent Advances (2025) · cites this paper as [39]
In the citing paper
“Given the role of GLP-1R-expressing VANs in physiological satiation (23, 39)”
From GLP-1 and the Neurobiology of Eating Control: Recent Advances (2025) · cites this paper as [39]
Citations
Cites
Functional and chemical anatomy of the afferent vagal system
Berthoud, H.-R., & Neuhuber, W. L. (2000) · Autonomic Neuroscience · doi:10.1016/s1566-0702(00)00215-0 · Cited by 1,280 · cited 13×
“We measured HPV blood glucose in the fasted and fed conditions in control and GLP-1R kd rats.”
BackgroundInfluentialSensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y
Erickson, J. C., Clegg, K. E., & Palmiter, R. D. (1996) · Nature · doi:10.1038/381415a0 · Cited by 1,008 · cited 2×
“Drugs GLP-1(7-36)amide (Bachem H-6795), Ex-4 (Bachem H-8730), and cholecystokinin octapeptide (CCK) (Bachem H-2080) were resuspended in sterile PBS and administered at doses of 33 mg/kg IP (GLP-1), 0.”
BackgroundMethodVilsboll, T., Christensen, M., Junker, A. E., Knop, F. K., & Gluud, L. L. (2012) · BMJ · doi:10.1136/bmj.d7771 · Cited by 970
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
Secher, A., Jelsing, J., Baquero, A. F., Hecksher-Sørensen, J., Cowley, M. A., Dalbøge, L. S., Hansen, G., Grove, K. L., Pyke, C., Raun, K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75276 · Cited by 961 · cited 2×
“Recent studies, however, have shown that GLP-1R agonists, such as liraglutide, exert their body weight and glucose-lowering effects independent of vagal afferents (45) and do not require VAN GLP-1Rs (17).”
BackgroundAbbott, C. R., Monteiro, M., Small, C. J., Sajedi, A., Smith, K. L., Parkinson, J. R. C., Ghatei, M. A., & Bloom, S. R. (2005) · Brain Research · doi:10.1016/j.brainres.2005.03.011 · Cited by 599 · cited 2×
“Drugs GLP-1(7-36)amide (Bachem H-6795), Ex-4 (Bachem H-8730), and cholecystokinin octapeptide (CCK) (Bachem H-2080) were resuspended in sterile PBS and administered at doses of 33 mg/kg IP (GLP-1), 0.”
BackgroundMethodVagal Sensory Neuron Subtypes that Differentially Control Breathing
Chang, R. B., Strochlic, D. E., Williams, E. K., Umans, B. D., & Liberles, S. D. (2015) · Cell · doi:10.1016/j.cell.2015.03.022 · Cited by 439 · cited 2×
“Drugs GLP-1(7-36)amide (Bachem H-6795), Ex-4 (Bachem H-8730), and cholecystokinin octapeptide (CCK) (Bachem H-2080) were resuspended in sterile PBS and administered at doses of 33 mg/kg IP (GLP-1), 0.”
BackgroundMethodGlucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms
I˙meryüz, N., Yeğen, B. Ç., Bozkurt, A., Coşkun, T., Villanueva-Peñacarrillo, M. L., & Ulusoy, N. B. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.4.g920 · Cited by 432
Qian, S., Chen, H., Weingarth, D., Trumbauer, M. E., Novi, D. E., Guan, X., Yu, H., Shen, Z., Feng, Y., Frazier, E., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.14.5027-5035.2002 · Cited by 430 · cited 2×
“Drugs GLP-1(7-36)amide (Bachem H-6795), Ex-4 (Bachem H-8730), and cholecystokinin octapeptide (CCK) (Bachem H-2080) were resuspended in sterile PBS and administered at doses of 33 mg/kg IP (GLP-1), 0.”
BackgroundMethodNeuronal GLP1R mediates liraglutide’s anorectic but not glucose-lowering effect
Sisley, S., Gutierrez-Aguilar, R., Scott, M., D’Alessio, D. A., Sandoval, D. A., & Seeley, R. J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72434 · Cited by 397 · cited 3×
“Drugs GLP-1(7-36)amide (Bachem H-6795), Ex-4 (Bachem H-8730), and cholecystokinin octapeptide (CCK) (Bachem H-2080) were resuspended in sterile PBS and administered at doses of 33 mg/kg IP (GLP-1), 0.”
BackgroundMethodResultKanoski, S. E., Fortin, S. M., Arnold, M., Grill, H. J., & Hayes, M. R. (2011) · Endocrinology · doi:10.1210/en.2011-0174 · Cited by 347 · cited 5×
“Together, this strengthens the classical view that VAN GLP-1Rs mainly mediate shortterm satiation and may be one of several redundant eating control mechanisms comprising the gut-brain axis (7,9,16,33).”
BackgroundMethodSelf-citation
Research works printed but not linked: 1
- Arnold, 2012, Intraperitoneal (IP) glucagon-like peptide-1 (GLP-1) injections and meals in rats increase intestinal lymphatic GLP-1 similarly, Appetite, 59, e3
Cited by
Items 101–200 of 265
Bae, J. H., Choi, H. J., Cho, K. I. K., Kim, L. K., Kwon, J. S., & Cho, Y. M. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0018 · Cited by 33
“Moreover, GLP-1 affects the hindbrain and vagal afferents, leading to meal termination [19-21].”
BackgroundHow gut hormones shape reward: A systematic review of the role of ghrelin and GLP-1 in human fMRI
Schulz, C., Vezzani, C., & Kroemer, N. B. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114111 · Cited by 33
Mechanistic insights into the liver–brain axis during chronic liver disease
Siddle, M. R., Durán, R. G., Goel, D., Renquist, B. J., Holt, M. K., & Hadjihambi, A. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01142-z · Cited by 41
Milano, W., Biasio, V. D., Munzio, W. D., Foggia, G., & Capasso, A. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200515112853 · Cited by 36
Functional interaction between Ghrelin and GLP-1 regulates feeding through the vagal afferent system
Zhang, W., Waise, T. M. Z., Toshinai, K., Tsuchimochi, W., Naznin, F., Islam, M. N., Tanida, R., Sakoda, H., & Nakazato, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-75621-5 · Cited by 34
The vagus neurometabolic interface and clinical disease
Battinelli, E., Valdés‐Ferrer, S. I., & Steinberg, B. E. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0086-1 · Cited by 36
Wen, S., Nguyen, T., Gong, M., Yuan, X., Wang, C., Jin, J., & Zhou, L. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s312527 · Cited by 30
Dorsal striatum dopamine oscillations: Setting the pace of food anticipatory activity
de Lartigue, G., & McDougle, M. J. (2018) · Acta Physiologica · doi:10.1111/apha.13152 · Cited by 34
“Antagonists of these hormones prevent lipid‐induced satiation(95-97) via a vagal‐dependent pathway.(93,98,99) Paracrine signalling between enteroendocrine cells and vagal afferent nerves innervating the gut is thought to be the main mechanism of fat signalling to the brain, although there is also preliminary evidence…”
Sloop, K. W., Briere, D. A., Emmerson, P. J., & Willard, F. S. (2018) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.8b00009 · Cited by 31
Stefanidis, A., & Oldfield, B. J. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12534 · Cited by 34
Peripheral and central regulation of insulin by the intestine and microbiome
Schertzer, J. D., & Lam, T. K. T. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00547.2020 · Cited by 36
Glucagon-like peptide-1 and insulin synergistically activate vagal afferent neurons
Iwasaki, Y., Goswami, C., & Yada, T. (2017) · Neuropeptides · doi:10.1016/j.npep.2017.05.003 · Cited by 34
Gastrointestinal Vagal Afferents and Food Intake: Relevance of Circadian Rhythms
Page, A. J. (2021) · Nutrients · doi:10.3390/nu13030844 · Cited by 34
“Further, GLP-1 receptors are expressed in rat VA neurons [66] and selective knockout of these receptors was associated with increased meal size, however, there was no long-term effects on energy balance [67].”
BackgroundVana, V., Lærke, M. K., Rehfeld, J. F., Arnold, M., Dmytriyeva, O., Langhans, W., Schwartz, T. W., & Hansen, H. S. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14575 · Cited by 31
Self-citationGlucagon‐like peptide‐1: The missing link in the metabolic clock?
Brubaker, P. L., & Gil‐Lozano, M. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12477 · Cited by 39
GLP-1 physiology and pharmacology along the gut-brain axis
Beutler, L. R. (2026) · Journal of Clinical Investigation · doi:10.1172/jci194744 · Cited by 35
“…circulating GLP-1 is rapidly degraded by dipeptidyl peptidase IV (DPPIV), it is believed to act largely in a paracrine or local rather than hormonal fashion, and it is unclear whether peripheral GLP-1 directly activates brain GLP-1R under physio-The physio-The Journal of Clinical Investigation”
InfluentialOhbayashi, K., Oyama, Y., Yamaguchi, C., Asano, T., Yada, T., & Iwasaki, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.676869 · Cited by 30
Roberts, C. A., Christiansen, P., & Halford, J. C. G. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-0994-x · Cited by 30
Neuroendocrine Peptides of the Gut and Their Role in the Regulation of Food Intake
Schalla, M. A., Taché, Y., & Stengel, A. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200007 · Cited by 30
Glucagon‐like peptide‐1 drives energy metabolism on the synaptic highway
Liu, J., & Pang, Z. P. (2016) · The FEBS Journal · doi:10.1111/febs.13785 · Cited by 28
Dischinger, U., Corteville, C., Otto, C., Fassnacht, M., Seyfried, F., & Hankir, M. K. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.04.008 · Cited by 26
Waise, T. M. Z., Rasti, M., Duca, F. A., Zhang, S., Bauer, P. V., Rhodes, C. J., & Lam, T. K. T. (2019) · Nature Communications · doi:10.1038/s41467-019-08582-7 · Cited by 26
An alternative pathway for sweet sensation: possible mechanisms and physiological relevance
von Molitor, E., Riedel, K., Krohn, M., Rudolf, R., Hafner, M., & Cesetti, T. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02467-1 · Cited by 31
“To better understand the role of GLP-1, its origin and region of action, CPIR induction should be investigated in conditional and regional knockouts or lentiviral models [147, 284] (for review, [62]), as well as upon tissue-specific reactivation of GLP-1 in loss-of-function mice [40].”
BackgroundSeeking satiety: From signals to solutions
Tschöp, M. H., & Friedman, J. M. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adh4453 · Cited by 30
“Tissue-specific GLP-1R knockouts suggest that its insulinotropic effect is mediated both via direct effects on pancreatic β cells and by stimulation of local vagal and spinal afferents in intestine ( 68 ).”
BackgroundStengel, A., & Taché, Y. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00498 · Cited by 25
“GLP-1 signals to the brain via the vagus nerve expressing the GLP-1 receptor (163) as shown by the suppression of the anorexigenic effect of peripherally injected GLP-1 by vagotomy (164, 165).”
BackgroundBorner, T., Shaulson, E. D., Tinsley, I. C., Stein, L. M., Horn, C. C., Hayes, M. R., Doyle, R. P., & Jonghe, B. C. D. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14089 · Cited by 25
“effects on feeding was unexpected given reports of a role of vagal afferent signalling in the mediation of the early-phase anorexia induced by both GLP-1 and native Ex4 in rats.(34,35) Our previous report also observed this effect in lean, healthy rats treated with the highest dose of B12-Ex4.”
BackgroundResultSmits, M. M., & Holst, J. J. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3699 · Cited by 25
“5,113,133,135 Based on these studies, the nodose ganglion is required for the actions of endogenous GLP ‐ 1 but neither nestin ‐ nor Wnt1 ‐ positive nerve cells, whereas the role of Phox2b ‐ positive cells needs further study.”
BackgroundGlucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism
HOFFMAN, S. S., & Adeli, K. (2024) · Medical Review · doi:10.1515/mr-2024-0011 · Cited by 26
“This reduction was lost upon surgical or pharmacological vagal dea ff erentation, or under conditions of adrenergic blockade – corroborating previous reports that GLP-1 both signals via the vagus and reduces plasma lipids via sympathetic signalling [66, 101].”
BackgroundNg, V. W. W., Gerard, G., Koh, J. J. K., Loke, K. Y., Lee, Y. S., & Ng, N. B. H. (2024) · Clinical Obesity · doi:10.1111/cob.12642 · Cited by 21
“18,36,37 In addition, circulating GLP-1 acts on GLP-1 receptors in areas of the hindbrain beyond the hypothalamus that are involved in appetite homeostasis.”
BackgroundVagal Sensory Gut–Brain Pathways That Control Eating—Satiety and Beyond
Méndez‐Hernández, R., Braga, I., Bali, A. P., Yang, M., & de Lartigue, G. (2025) · Comprehensive physiology · doi:10.1002/cph4.70010 · Cited by 25
“Given that the deletion of GLP-1R on vagal sensory neurons influences feeding and glucose homeostasis (Krieger et al. 2016), further research is needed to fully resolve the mechanism of GLP-1 signaling on VANs.”
Estrogen and gut satiety hormones in vagus-hindbrain axis
Huang, K.-P., & Raybould, H. E. (2020) · Peptides · doi:10.1016/j.peptides.2020.170389 · Cited by 24
The vagus nerve mediates the physiological but not pharmacological effects of PYY3-36 on food intake
Alonso, A. M., Cork, S. C., Phuah, P., Hansen, B., Norton, M., Cheng, S., Xu, X., Suba, K., Ma, Y., Dowsett, G. K. C., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101895 · Cited by 22
“…vagus, where it is thought to modulate the sensitivity of mechanosensitive vagal afferent endings [31,32] Thus, loss of the GLP-1 receptor on vagal afferents in rats results in longer and larger meals [24], as might be more expected of a hormone that mediates gastric distension-induced satiety.”
BackgroundResultSelf-citationPhysiology, pathophysiology and therapeutic implications of enteroendocrine control of food intake
Elliott, J. A., Reynolds, J. V., le Roux, C. W., & Docherty, N. G. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2016.1245140 · Cited by 22
García-Luna, C., Sanchez‐Watts, G., Arnold, M., de Lartigue, G., DeWalt, N., Langhans, W., & Watts, A. G. (2021) · eNeuro · doi:10.1523/eneuro.0419-20.2021 · Cited by 23
“Virus injections into the LNG was performed as previously described (Krieger et al., 2016, 2018; Lee et al., 2020).”
Self-citationLimiting glucocorticoid secretion increases the anorexigenic property of Exendin-4
Lee, S. J., Diener, K., Kaufman, S., Krieger, J.-P., Pettersen, K. G., Jejelava, N., Arnold, M., Watts, A. G., & Langhans, W. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.04.008 · Cited by 20
“In the present study, an Ex-4-induced inhibition of PPG mRNA expression was not observed after DSAP lesion which was paralleled by an impaired HPA response to Ex-4, consistent with the idea that HPA axis activation inhibits central GLP-1 production.”
BackgroundSelf-citationPacini, G., & Åhrén, B. (2017) · Physiological Reports · doi:10.14814/phy2.13280 · Cited by 21
“2002) in stimulating insulin secretion (Krieger et al. 2016).”
BackgroundResultA homeostatic gut-to-brain insulin antagonist restrains neuronally stimulated fat loss
Liu, C., Khan, A., Seban, N., Littlejohn, N. K., Shah, A., & Srinivasan, S. (2024) · Nature Communications · doi:10.1038/s41467-024-51077-3 · Cited by 21
α7 Nicotinic Acetylcholine Receptor Regulates the Function and Viability of L Cells
Wang, D., Meng, Q., Leech, C. A., Yepuri, N., Zhang, L., Holz, G. G., Wang, C., & Cooney, R. N. (2018) · Endocrinology · doi:10.1210/en.2018-00433 · Cited by 20
Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions
English, A. R., & Irwin, N. (2019) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/1179551419888871 · Cited by 21
Rapid hepatic metabolism blunts the endocrine action of portally infused GLP-1 in male rats
Aulinger, B. A., Perabò, M., Seeley, R. J., Parhofer, K. G., & D’Alessio, D. A. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00298.2019 · Cited by 21
“It has been suggested by several groups that neuroendocrine signaling through the GLP-1r originates proximal to the portal vein within the substance of the intestine (17, 23, 39) in which local GLP-1 concentrations are even higher than in the portal vein (9).”
BackgroundMalbert, C.-H., Chauvin, A., Horowitz, M., & Jones, K. L. (2021) · Diabetes · doi:10.2337/db20-0361 · Cited by 18
A Rat Model of Human Lipid Emulsion Digestion
Steingoetter, A., Arnold, M., Scheuble, N., Fedele, S., Bertsch, P., Liu, D., Parker, H. L., Langhans, W., & Fischer, P. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00170 · Cited by 18
“After infusing the emulsions, gastric emptying was measured by the paracetamol absorption test and recorded food intake as well as postprandial profiles of metabolites and GI hormones in separate experiments (34).”
MethodSelf-citationLong-acting glucagon-like peptide-1 receptor agonist—status December 2018
Holst, J. J. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.01.09 · Cited by 21
“Endogenous GLP-1 is thought to signal to the brain via sensory afferents of the vagus nerve (15), terminating in the nucleus of the solitary tract in the brain stem, whereas exogenous GLP-1 and the GLP-1RAs probably mainly reach the Table 1 Possible actions of GLP-1 and the GLP-1 RAs”
BackgroundLi, R. J. W., Barros, D. R., Kuah, R., Lim, Y.-M., Gao, A., Beaudry, J. L., Zhang, S., & Lam, T. K. T. (2024) · Nature Metabolism · doi:10.1038/s42255-023-00942-4 · Cited by 19
“Of note, the fact that casein induced changes in portal, but not systemic, GLP1 and GIP levels during IVGTT protocol indicates that portal–vagal-mediated pathways may be involved in glucose regulation 40–44 .”
Khan, T. T. S., Sheikh, Z., Maleknia, S. D., Oveissi, F., Fathi, A., Abrams, T., Ong, H. X., & Traini, D. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2387110 · Cited by 21
“The relevance of vagal afferent response in regulating eating behavior was evident when a virus-mediated knockdown of GLP-1 R in vagal afferent neurons of rats was found to increase the meal intake portion and accelerate the rate of gastric emptying [37].”
Cao, N., Merchant, W., & Gautron, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-74000-8 · Cited by 22
Masuda, Y., Ohbayashi, K., & Iwasaki, Y. (2025) · Diabetology International · doi:10.1007/s13340-025-00819-9 · Cited by 17
Bookout, A. L., & Gautron, L. (2020) · The Journal of Comparative Neurology · doi:10.1002/cne.24936 · Cited by 16
“…into NG is an increasingly popular tool which is used as a mean to alter gene expression in vagal afferents in a selective manner (Bai et al., 2019; Chang, Strochlic, Williams, Umans, & Liberles, 2015; Diepenbroek et al., 2017; Han et al., 2018; Krieger et al., 2016; Nonomura et al., 2017).”
MethodMonitoring In Vivo Neural Activity to Understand Gut–Brain Signaling
Alhadeff, A. L. (2021) · Endocrinology · doi:10.1210/endocr/bqab029 · Cited by 20
The brain–gut axis, inflammatory bowel disease and bioelectronic medicine
Eberhardson, M., Levine, Y. A., Tarnawski, L., & Olofsson, P. S. (2021) · International Immunology · doi:10.1093/intimm/dxab018 · Cited by 18
Krieger, J.-P., Langhans, W., & Lee, S. J. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.03.037 · Cited by 17
Self-citationGrasset, E., Puel, A., Charpentier, J., Klopp, P., Christensen, J. E., Lelouvier, B., Servant, F., Blasco‐Baqué, V., Tercé, F., & Burcelin, R. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01790-y · Cited by 16
Douros, J. D., Flak, J. N., & Knerr, P. J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1530985 · Cited by 18
Yada, T., Dezaki, K., & Iwasaki, Y. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00168.2025 · Cited by 16
Victorino, D. B., Nejm, M. B., Guimarães‐Marques, M., Scorza, F. A., & Scorza, C. A. (2021) · Pharmaceutical Medicine · doi:10.1007/s40290-020-00374-5 · Cited by 19
A sandwich ELISA for measurement of the primary glucagon-like peptide-1 metabolite
Albrechtsen, N. J. W., Asmar, A., Jensen, F. H., Toräng, S., Simonsen, L., Kuhre, R. E., Asmar, M., Veedfald, S., Plamboeck, A., Knop, F. K., et al. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00005.2017 · Cited by 15
“It plays an essential role for postprandial glucose regulation (20) by potentiating glucose-induced insulin secretion (16).”
BackgroundOkada, T., Waise, T. M. Z., Toshinai, K., Mita, Y., Sakoda, H., & Nakazato, M. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.05.035 · Cited by 16
Charpentier, J., Waget, A., Klopp, P., Magnan, C., Cruciani‐Guglielmacci, C., Lee, S. J., Burcelin, R., & Grasset, E. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00348.2017 · Cited by 15
“Reducing GLP-1 receptor signaling in the neurons of the vagus nerve via viral-mediated GLP-1 receptor knockdown in the nodose ganglia influences glucose-induced insulin secretion and gastric emptying (31).”
BackgroundInfluentialSelf-citationJones, S., Hyde, A., & Davidson, T. L. (2020) · Nutrition Research · doi:10.1016/j.nutres.2020.05.001 · Cited by 18
“In the periphery, GLP-1 analogues activate receptors on vagal afferent neurons which are known to influence brain function not only in response to endogenous GLP-1 [88], but to gastrointestinal signals at large [89,90].”
BackgroundPhysiological and pharmacological actions of glucagon like peptide-1 (GLP-1) in domestic animals
Model, J. F. A., Rocha, D. S., Fagundes, A. D. C., & Vinagre, A. S. (2022) · Veterinary and Animal Science · doi:10.1016/j.vas.2022.100245 · Cited by 18
The Role of the Gut-Brain Axis in Diseases
Chen, J. W., Xu, Y., & Cao, P. (2025) · Physiology · doi:10.1152/physiol.00016.2025 · Cited by 18
Glucagon‐Like Peptide‐1 Links Ingestion, Homeostasis, and the Heart
Krieger, J., Daniels, D., Lee, S. J., Mastitskaya, S., & Langhans, W. (2024) · Comprehensive physiology · doi:10.1002/cph4.7 · Cited by 15
Self-citationIncretin receptor agonism rapidly inhibits AgRP neurons to suppress food intake in mice
McMorrow, H. E., Cohen, A. B., Lorch, C. M., Hayes, N. W., Fleps, S. W., Frydman, J. A., Xia, J. L., Samms, R. J., & Beutler, L. R. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186652 · Cited by 12
“Emissions were collected through the patch cords”
The protective role of GLP-1 in neuro-ophthalmology
Sheth, S., Patel, A., Foreman, M. A., Mumtaz, M., Reddy, A., Sharaf, R., Sheth, S., & Lucke-Wold, B. P. (2023) · Exploration of Drug Science · doi:10.37349/eds.2023.00015 · Cited by 15
Patil, M., Casari, I., Warne, L. N., & Falasca, M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116245 · Cited by 12
Vetrugno, L., Deana, C., Porto, A. D., Boero, E., Bellini, V., Biasucci, D. G., & Bignami, E. G. (2025) · Journal of Anesthesia Analgesia and Critical Care · doi:10.1186/s44158-025-00237-y · Cited by 14
Vagal oxytocin receptors are necessary for esophageal motility and function
Asker, M., Krieger, J.-P., Marić, I., Bedel, E., van der Steen, J. T., Börchers, S., Wen, Y., Longo, F., Aronsson, P., Winder, M., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.190108 · Cited by 13
“To reduce vagal OTR, we employed a virogenetic knockdown (Kd) technique targeted to the nodose ganglia of male and female rats (6, 20, 53).”
Self-citationde Sousa, É., Sparks, L. M., & Townsend, K. L. (2025) · Diabetes · doi:10.2337/db25-0158 · Cited by 13
Meng, Q., Chepurny, O. G., Leech, C. A., Pruekprasert, N., Molnar, M. E., Collier, J. J., Cooney, R. N., & Holz, G. G. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14693 · Cited by 12
Intestinal lymph as a readout of meal-induced GLP-1 release in an unrestrained rat model
Jejelava, N., Kaufman, S., Krieger, J.-P., Terra, M. M., Langhans, W., & Arnold, M. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00120.2017 · Cited by 12
“Endogenous GLP-1 that is released in response to meals affects eating, gastric emptying, and glycemia at least in part by acting on GLP-1 receptors on these vagal afferents terminating in the intestinal wall (17).”
BackgroundSelf-citationThe Enteroendocrine System in Obesity
Miedzybrodzka, E. L., Reimann, F., & Gribble, F. M. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2022_582 · Cited by 12
Optogenetic Control of the Peripheral Nervous System
Chang, R. B. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034397 · Cited by 13
Novel neural pathways targeted by GLP-1R agonists and bariatric surgery
Hankir, M. K., & Lutz, T. A. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-03047-3 · Cited by 16
“This has received support in more recent studies with GLP-1R agonists [7, 28] and PYY 3–36 [29], provided that they were administered at lower (more physiological) doses.”
Nowacka, A., Śniegocki, M., & Ziółkowska, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167812 · Cited by 14
“Krieger et al. [51,127] demonstrated that these inputs affect satiation timing and inter-meal intervals, and their disruption may lead to erratic eating patterns.”
Haspula, D., & Cui, Z. (2023) · Cells · doi:10.3390/cells12131801 · Cited by 14
Minaya, D. M., Kim, J. S., Kirkland, R. A., Allen, J. T., Cullinan, S., Maclang, N., de Lartigue, G., & Serre, C. B. D. L. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2421581 · Cited by 12
“101,102 CART neuropeptide expression is induced in the NG upon feeding, and this response is mediated by CCK. 21,22 CART and CCK-mediated vagal signaling is further associated with c-Fos expression, a marker of neuronal activation, in the NTS and other central areas involved in the control of food…”
BackgroundAdvances in the biosynthesis of D-allulose
Zhang, Y., Zhou, Z., Luan, H., Zhang, X., Liu, M., Wang, K., Fei, W., Feng, W., Xu, W., & Song, P. (2024) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-024-04166-w · Cited by 9
Trapp, S., & Skoug, C. (2025) · Endocrinology · doi:10.1210/endocr/bqaf169 · Cited by 12
“Activation of GLP-1Rs inside the BBB could potentially replicate either the action of gut-derived GLP-1 gaining access to the brain, or the action of PPG neurons.”
InfluentialSonne, N., Roque, M., Zachariassen, L. F., Porsgaard, T., Pors, S. E., Cavalera, M., Jones, C., Osborn, O., Thorbek, D. D., Riis, M. L., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106121 · Cited by 9
“68 71 Given that orforglipron did not significantly stimulate c-Fos expression in the NTS, AP, and DMX, this may reflect reduced engagement of the DVC and its associated vagal pathways in the modulation of gastric emptying, relative to semaglutide.”
Upregulated Pdx1 and MafA Contribute to β-Cell Function Improvement by Sleeve Gastrectomy
Li, F., Cao, H., Sheng, C., Sun, H., Song, K., & Qu, S. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2068-5 · Cited by 9
Sex Difference In the Effect of Fetal Exposure to Maternal Diabetes on Insulin Secretion
Gautier, J., Fetita, L.-S., Riveline, J., Ibrahim, F., Porcher, R., Khalil, C. A., Velho, G., Choukem, S. P., Hadjadj, S., Larger, É., et al. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2017-00482 · Cited by 9
Souders, C. L., Zubcevic, J. A., & Martyniuk, C. J. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01044-z · Cited by 10
Brain Defense of Glycemia in Health and Diabetes
Mirzadeh, Z., & Faber, C. L. (2024) · Diabetes · doi:10.2337/dbi24-0001 · Cited by 9
Ghrelin–LEAP2 interactions along the stomach–liver axis
Sakai, K., Nakazato, Y., Shiimura, Y., Zhang, W., & Nakazato, M. (2024) · Endocrine Journal · doi:10.1507/endocrj.ej24-0543 · Cited by 8
Alcaino, C., Reimann, F., & Gribble, F. M. (2024) · The Journal of Physiology · doi:10.1113/jp286293 · Cited by 10
“The ileal brake is thought to be mediated by vagal innervation, as selective knockdown of Glp1r in vagal afferent neurons not only increased food intake, but also accelerated gastric emptying in a rat model (Krieger et al., 2016).”
Anti‐incretin effect: The other face of Janus in human glucose homeostasis
Karras, S. Ν., Koufakis, T., Mustafa, O. G., & Kotsa, K. (2019) · Obesity Reviews · doi:10.1111/obr.12917 · Cited by 7
“Previous results in a rat model demonstrated that specific knockdown of vagal afferent neurons of GLP‐1 receptors resulted in an increase in meal size, accelerated gastric emptying postmeal glycemia, and disruption of insulin release.(83) These results indicate that vagal afferent neurons of GLP‐1 receptors are requir…”
ResultVana, V., Lærke, M. K., Kleberg, K., Mroz, P. A., Lindberg, B. L., Ekberg, J. H., Rehfeld, J. F., Schwartz, T. W., & Hansen, H. S. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113315 · Cited by 7
Luo, S., Zhu, H., Huang, H.-F., & Ding, G. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02069-5 · Cited by 7
“glucose stimulation, insulin secretion is mostly dependent on the glucose stimulus of the islet, however, in response to oral glucose, insulin secretion is also dependent on gut incretins acting on the gut-brain-islet axis [54, 55].”
BackgroundAfferent Endocrine Control of Eating
Langhans, W., & Holst, J. J. (2016) · Wiley eBooks · doi:10.1002/9781118839317.ch2 · Cited by 7
Self-citationThe Enteric Neuronal Circuitry: A Key Ignored Player in Nutrient Sensing Along the Gut–Brain Axis
Nikolla, E., Grandberry, A., Jamerson, D., Flynn, C. R., & Sundaresan, S. (2025) · The FASEB Journal · doi:10.1096/fj.202500220rr · Cited by 7
“Some of the hormones that commonly mediate food intake are CCK and glucagon-like peptide 1 (GLP-1), with GLP-1 known to directly impact glucose control [17, 18].”
Zhou, M., Zhao, Y., Chu, C.-L., Behera, T. R., Shen, Q., & Xing, Y.-B. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i9.110053 · Cited by 6
Ohbayashi, K., Sugiyama, Y., Nohmi, T., Nishimura, K., Nakazaki, T., Sato, Y., Masumura, T., & Iwasaki, Y. (2024) · The Journal of Physiological Sciences · doi:10.1186/s12576-024-00940-5 · Cited by 7
“Recent studies have shown that endogenous GLP-1 promotes not only insulin release but also insulin action through brain–systemic crosstalk initiated by the activation of vagal afferent nerves expressing GLP-1 receptors [23–26].”
BackgroundSchooling, C. M., Yang, G., Soliman, G. A., & Leung, G. M. (2025) · Life · doi:10.3390/life15020253 · Cited by 9
“In addition, GLP1-RAs act via vagal afferents [42], which also affect AMPK activity [43].”
Abilities of Rare Sugar Members to Release Glucagon-like Peptide-1 and Suppress Food Intake in Mice
Masuda, Y., Ohbayashi, K., Iba, K., Kitano, R., Kimura, T., Yamada, T., Hira, T., Yada, T., & Iwasaki, Y. (2025) · Nutrients · doi:10.3390/nu17071221 · Cited by 8
“The enhancement of GLP-1 secretion from the gut by food or D-allulose is known to contribute to the short-term suppression of food intake [13,14].”
Veedfald, S., Hansen, M., Christensen, L. W., Larsen, S. A. H., Hjøllund, K. R., Plamboeck, A., Hartmann, B., Deacon, C. F., & Holst, J. J. (2016) · Experimental Physiology · doi:10.1113/ep085692 · Cited by 6
“Krieger et al. (2016) used a lentiviral vector to knock down vagal afferent neuron GLP-1 receptors in rats and found elevated postprandial glycaemia and blunted insulin release, suggesting a role of vagal transmission for the effects of endogenous GLP-1.”
Mhalhal, T. R., Washington, M. C., Newman, K. D., Heath, J. C., & Sayegh, A. I. (2017) · Neuropeptides · doi:10.1016/j.npep.2017.11.009 · Cited by 6
Chou, I.-W., Cheng, R. Y.-H., Chen, Y., Hsieh, P. C. H., & King, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-12290-x · Cited by 7
Gut–vagus–NTS neural pathway in controlling feeding behaviors
Chen, J. W., & Zhan, C. (2023) · Stress and Brain · doi:10.26599/sab.2023.9060033 · Cited by 6
Semi-microbiological synthesis of an active lysinoalanine-bridged analog of glucagon-like-peptide-1
Kuipers, A., de Vries, L., de Vries, M. P., Rink, R., Bosma, T., & Moll, G. N. (2017) · Peptides · doi:10.1016/j.peptides.2017.03.004 · Cited by 5
The metabolic effect of medicinal plants and synthetic anti-obesity products on human health
Al-Shammary, Z. A. A., & Alshammaa, D. A. S. (2024) · Plant Science Today · doi:10.14719/pst.3206 · Cited by 6
Metadata
- Authors
- Krieger, J.-P., Arnold, M., Pettersen, K. G., Lossel, P., Langhans, W., & Lee, S. J.
- Affiliations
- ETH Zurich (CH)
- Corresponding author
- Krieger, Jean-Philippe
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2015-10-15
- Volume
- 65
- Issue
- 1
- Pages
- 34-43
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2180065345
- Cited by
- 269
- References
- 43
- Citations by year
- 2026: 24 · 2025: 30 · 2024: 36 · 2023: 15 · 2022: 19 · 2021: 33 · 2020: 26 · 2019: 21 · 2018: 24 · 2017: 23 · 2016: 17 · 2015: 1
- FWCI
- 12.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- ETH Zurich (4712-2)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- GLP-1 receptor, vagal afferent neurons, nodose ganglion, gene knockdown, dietary intake, glycemia, insulin secretion, gastric emptying, meal size, energy homeostasis, enteroendocrine L cells
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Insulin Secretion, Animals, Blood Glucose, Eating, Energy Metabolism, Gastric Emptying, Insulin, Intestines, Male, Neurons, Afferent, Nodose Ganglion, Vagus Nerve, Rats, Sprague-Dawley, Postprandial Period, Rats, Gene Knockdown Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.